Dallas - With one biologic therapy approved by the United States Food and Drug Administration for the treatment of psoriasis and three in various stages of the approval process, new treatment options are adding a new level to psoriasis care.
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
Managing Food Allergies with Dupilumab in Pediatric Dermatology